Chemical inhibitors of TMEM128 target various signaling pathways and cellular processes to exert their inhibitory effects. Wortmannin and LY294002 both act as inhibitors of phosphoinositide 3-kinases (PI3K), which are critical in numerous intracellular signaling pathways. By inhibiting PI3K, these chemicals disrupt the downstream signaling that may be vital for the proper functioning of TMEM128. Similarly, Staurosporine, through its broad-spectrum inhibition of protein kinases, may impede phosphorylation processes essential for TMEM128 or its associated proteins, thereby inhibiting the functional activities of TMEM128. Rapamycin specifically targets mTOR pathways that are fundamental to cellular metabolism and growth; this inhibition can lead to a disturbance in cellular processes that TMEM128 relies on for its function.
In addition to these, SB203580 and PD98059 focus on the MAPK pathway, with SB203580 inhibiting p38 MAP kinase and PD98059 selectively inhibiting MEK. These kinases participate in a range of cellular responses, including differentiation and apoptosis, which TMEM128 may be involved in. By inhibiting these kinases, SB203580 and PD98059 can interrupt the signaling cascades TMEM128 requires. SP600125 and U0126 target the stress response and ERK pathway, respectively, with SP600125 inhibiting JNK and U0126 targeting MEK1/2, potentially disrupting TMEM128 function by impeding crucial signaling pathways. Y-27632's inhibition of ROCK can lead to cytoskeletal organization changes, negatively impacting cellular processes that TMEM128 depends on for its role. Chemicals like Bisindolylmaleimide I and PP2 inhibit PKC and Src family kinases, respectively, both of which are integral to various signaling mechanisms. By inhibiting these kinases, Bisindolylmaleimide I and PP2 can lead to a reduction in TMEM128 activity through disruption of its required signaling pathways. Lastly, Gefitinib inhibits EGFR tyrosine kinase, which blocks essential signaling pathways for TMEM128 function, resulting in the inhibition of the protein. Through these diverse mechanisms, each chemical contributes to the inhibition of TMEM128 by targeting specific pathways and processes that the protein relies on.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of phosphoinositide 3-kinases (PI3K), which can lead to the inhibition of downstream signaling pathways that may be critical for TMEM128 function, resulting in functional inhibition of TMEM128. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K), disrupting PI3K-dependent signaling pathways that could be essential for TMEM128 activity, thereby inhibiting TMEM128 function. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, including those that may phosphorylate TMEM128 or its interacting partners, thus potentially inhibiting TMEM128's function through the alteration of its phosphorylation state. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin specifically inhibits mTOR (mechanistic target of rapamycin) which is involved in many signaling pathways; inhibition of mTOR could disrupt cellular processes essential for TMEM128 function, thereby inhibiting TMEM128. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase, which plays a role in cell differentiation, apoptosis, and autophagy; inhibition of p38 MAP kinase can interrupt pathways that TMEM128 may be involved in, thus inhibiting its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 selectively inhibits MEK, which is upstream of ERK in the MAPK pathway, potentially disrupting signaling cascades necessary for the functional activity of TMEM128, leading to its inhibition. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is implicated in stress response pathways; inhibition of JNK can disrupt signaling required for TMEM128 function, thereby inhibiting it. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2, which prevents the activation of ERK pathway; by inhibiting the ERK pathway, U0126 could disrupt necessary signaling for TMEM128 function, resulting in inhibition of TMEM128. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 is a selective inhibitor of ROCK (Rho-associated coiled-coil containing protein kinase), which is involved in cytoskeleton organization; inhibition of ROCK could impair cellular processes that TMEM128 depends on, leading to its inhibition. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Bisindolylmaleimide I is a specific inhibitor of protein kinase C (PKC), which is involved in various signaling pathways; by inhibiting PKC, it could disrupt functions that are crucial for TMEM128 activity, thereby inhibiting it. | ||||||